Westside Investment Management, Inc. Harrow Health, Inc. Transaction History

Westside Investment Management, Inc.

$626 Billion
Q3 2025

A detailed history of Westside Investment Management, Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Westside Investment Management, Inc. holds 179,576 shares of HROW stock, worth $7.32 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares

179,576

Previous 181,056 0.82%

Holding current value

$7.32 Million

Previous $5.53 Billion 56.47%

% of portfolio

1.38%

Previous 1.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	SELL	$30.57 - $48.85 $45,243 - $72,298	-1,480 Reduced 0.82%	179,576 $8.65 Billion
Q2 2025 Aug 05, 2025	BUY	$22.2 - $31.61 $159,840 - $227,592	7,200 Added 4.14%	181,056 $5.53 Billion
Q1 2025 Apr 25, 2025	BUY	$22.22 - $36.67 $229,199 - $378,251	10,315 Added 6.31%	173,856 $4.62 Billion
Q4 2024 Jan 17, 2025	SELL	$33.39 - $57.5 $80,236 - $138,172	-2,403 Reduced 1.45%	163,541 $5.49 Billion
Q3 2024 Nov 20, 2024	SELL	$20.85 - $46.47 $917,400 - $2.04 Million	-44,000 Reduced 20.96%	165,944 $7.45 Billion

Q2 2024 Jul 17, 2024	SELL	$10.0 - $21.64 $16,350 - $35,381	-1,635 Reduced 0.77%	209,944 $4.39 Billion
Q1 2024 Apr 19, 2024	SELL	$9.3 - $13.23 $6,835 - $9,724	-735 Reduced 0.35%	211,579 $2.8 Billion
Q4 2023 Jan 12, 2024	BUY	$8.1 - $16.36 $431,689 - $871,906	53,295 Added 33.51%	212,314 $2.38 Billion
Q3 2023 Nov 15, 2023	BUY	$14.03 - $22.08 $354,608 - $558,072	25,275 Added 18.9%	159,019 $2.29 Billion
Q2 2023 Jul 14, 2023	SELL	$17.37 - $28.08 $292,945 - $473,569	-16,865 Reduced 11.2%	133,744 $2.55 Billion
Q1 2023 May 17, 2023	SELL	$13.84 - $21.46 $542,943 - $841,875	-39,230 Reduced 20.66%	150,609 $3.19 Billion
Q4 2022 Jan 31, 2023	SELL	$10.28 - $14.78 $91,749 - $131,911	-8,925 Reduced 4.49%	189,839 $2.8 Million
Q3 2022 Nov 09, 2022	BUY	$6.57 - $24.88 $7,227 - $27,368	1,100 Added 0.56%	198,764 $2.4 Million
Q2 2022 Jul 15, 2022	BUY	$5.75 - $7.74 $115,828 - $155,914	20,144 Added 11.35%	197,664 $1.44 Million
Q1 2022 Apr 25, 2022	BUY	$6.77 - $8.66 $158,688 - $202,990	23,440 Added 15.21%	177,520 $1.21 Million
Q4 2021 Feb 15, 2022	SELL	$8.5 - $12.0 $6,970 - $9,840	-820 Reduced 0.53%	154,080 $1.33 Million
Q3 2021 Oct 27, 2021	BUY	$6.99 - $10.6 $250,766 - $380,275	35,875 Added 30.14%	154,900 $1.41 Million
Q2 2021 Jul 28, 2021	BUY	$6.68 - $11.07 $282,230 - $467,707	42,250 Added 55.03%	119,025 $1.11 Million
Q1 2021 Apr 14, 2021	BUY	$6.26 - $11.03 $34,117 - $60,113	5,450 Added 7.64%	76,775 $518,000
Q4 2020 Jan 15, 2021	BUY	$4.76 - $6.93 $43,673 - $63,582	9,175 Added 14.76%	71,325 $489,000
Q2 2020 Jul 21, 2020	BUY	$3.61 - $6.47 $5,415 - $9,705	1,500 Added 2.47%	62,150 $323,000
Q1 2020 Apr 16, 2020	BUY	$3.5 - $7.31 $131,950 - $275,587	37,700 Added 164.27%	60,650 $231,000
Q2 2019 Jul 24, 2019	BUY	$4.2 - $8.7 $96,390 - $199,664	22,950 New	22,950 $199,000

Others Institutions Holding HROW

# of Institutions

218

Shares Held

21.7M

Call Options Held

998K

Put Options Held

593K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.1B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.

Account

Westside Investment Management, Inc. Harrow Health, Inc. Transaction History